DESMOID TUMORS MARKET ANALYSIS

Desmoid Tumors Market, By Drug Type (Non-steroidal anti-inflammatory drugs(NSAIDs), Targeted Therapy, Chemotherapy, Hormone Therapy, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Retail Pharmacies), and By Geography (Asia-Pacific , North America, Europe, South America, Middle East & Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Dec 2022
Code : CMI5449
Pages :457
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Desmoid Tumors Market - Key Players

Major players operating in the global desmoid tumors market include Horizon Therapeutics Plc, Strides Pharma Science Limited, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals PLC, Natco Pharma Ltd, Lupin, Zydus Lifesciences, Mylan N.V., Assertio Holdings, Inc., Mayne Pharma Group Limited, Alembic Pharmaceuticals Limited, Aprazer, Ayala Pharmaceuticals, SpringWorks Therapeutics, Inc., Iterion Therapeutics, Novartis AG, Apotex Inc., Bayer AG., Sun Pharmaceutical Industries Ltd, Dr. Reddy’s Laboratories Ltd., Endo International plc, Abbott, and Getwell Pharmaceuticals

DESMOID TUMORS MARKET ANALYSIS

Leading Companies

Desmoid Tumors Market Report Snapshots

EXISTING CLIENTELE